Cancer specialists at Children’s National in Washington, D.C., provide expert treatment for children who have acute lymphoblastic leukemia. Learn more about this condition, including its symptoms, what causes and how we treat it.
Retinoblastoma is a rare cancer of the retina (the innermost layer of the eye, located at the back of the eye, that receives light and images necessary for vision).
A brain tumor is an abnormal growth of tissue in the brain or spinal cord. Learn more about this condition.
Leukemia is the most common form of pediatric cancer. Leukemia is cancer of the blood and develops in the bone marrow. Learn more about this condition.
Rhabdomyosarcoma is a cancerous tumor that originates in the soft tissues of the body, including the muscles, tendons and connective tissues.
Soft tissue sarcoma is a type of cancer that grows in soft tissues that support and connect parts of the body.
Non-Hodgkin lymphoma is cancer in the lymphatic system. The lymphatic system is part of the immune system and functions to fight disease and infections. Learn more about its causes and treatments.
Nasopharyngeal carcinoma is a rare type of cancer that occurs in the nasal cavity and the pharynx, the upper part of the throat behind the nose. Learn more about its causes and treatments.
Germ cell tumors are tumors that are comprised mostly of germ cells. Germ cells are the cells that develop and become the cells that make up the reproductive system. Learn more about this condition.
Pediatric neuroblastoma is a cancerous tumor that begins in nerve tissue of infants and very young children.
We deliver comprehensive care for all blood cancers including chemotherapy, bone marrow transplant and experimental therapeutics.
Orthopaedists at Children’s National offer world-renowned expertise and life-changing care, including surgery, for children at high risk for bone fracture.
Our Solid Tumor Program has a dedicated team of sarcoma experts who specialize in the newest treatments and clinical trials.
Our oncology (cancer) team provides personalized treatment plans for children with cancer, including access to clinical trials.